ANTI-HUMAN MELANOMA ACTIVITY OF Fe(III)-CONTAINING WELLS- DAWSON POLYANION: THE EFFECT OF ASCORBATE

17th International Conference on Fundamental and Applied Aspects of Physical Chemistry (Proceedings, Volume II) (2024) [O-06-P, pp. 607-610]  

AUTHOR(S) / AUTOR(I): Danijela Z. Krstić , Jelena J. Žakula , Lela B. Korićanac , Nada Savić , Tatjana Parac-Vogt and Mirjana B. Čolović   

Download Full Pdf  

DOI: 10.46793/Phys.Chem24II.607K

ABSTRACT / SAŽETAK:

This study aimed to investigate the simultaneous effect of Fe(III)-substituted monolacunary Wells-Dawson polyoxometalate (Fe-WD), K7[FeIII(α2-P2W17O61)(H2O)] and L(+)-ascorbic acid sodium salt (ascorbate) on cell viability of human melanoma A375 cells. A375 cells were exposed in vitro to Fe-WD (0.001 – 1 mM), ascorbate (0.040 – 40 mM), and Fe-WD/ascorbate mixtures (concentration ratio 1:40) for 24, 48, and 72 h. Fe-WD and ascorbate inhibited cell viability in a concentration-dependent manner for three treatment durations. Obtained EC50 values were 1, 0.58, and 0.52 mM (for 24-, 48-, and 72-hour exposure, respectively) for Fe-WD and 1.32, 1.12, and 0.80 mM (for 24, 48, and 72 hours, respectively) for ascorbate. The simultaneous exposure to Fe-WD/ascorbate mixtures resulted in cytotoxic effects weaker than the mathematical sum of effects induced by single Fe-WD and ascorbate treatments, indicating an antagonistic inhibitory effect of the studied compounds on A375 cell viability. Conclusively, Fe-WD seems to reduce the cytotoxic effect of sodium ascorbate due to the possible autoxidation of ascorbate by oxygen in the presence of ferric (Fe(III)) ions.

KEYWORDS / KLJUČNE REČI:

ACKNOWLEDGEMENT / PROJEKAT:

This study was funded by the Ministry of Science, Technological Development, and Innovation of the Republic of Serbia (contracts no. 451-03-66/2024-03/200017 and 451-03-9/2023-14/200110). The authors would also like to thank the Science Fund of the Republic of Serbia (POMCACT project no. 6526393).

REFERENCES / LITERATURA:

  • V. Brabec, O. Hrabina, J. Kasparkova, Coordin. Chem. Rev., 351 (2017) 2.
  • N. P. Farrell, Chem. Soc. Rev., 44 (2015) 8773.
  • M. B. Čolović, M. Lacković, J. Lalatović, A. S. Mougharbel, U. Kortz, D. Krstić, Curr. Med. Chem., 27 (2020) 362.
  • A. M. Isakovic, M. B. Čolović, T. Ma, X. Ma, M. Jeremić, M. Gerić, G. Gajski, S. Misirlic- Dencic, U. Kortz, Z. Krstić, J. Biol. Inorg. Chem., 26 (2021) 957.
  • S. A. M. Abdelhameed, F. de Azambuja, T. Vasović, N. D. Savić, T. Ćirković Veličković, T. N. Parac-Vogt, Nat. Commun., 14 (2023) 486.
  • A. P. Ginsberg, Inorganic Syntheses, John Wiley and Sons, New York, USA, 1990.
  • P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, M. R. Boyd, JNCI-J. Natl. Cancer I., 82 (1990) 1107.